ZMIZ1 and adrenal carcinoma: Next, we further assessed the role of the SWI/SNF-mediated complexes in ZMIZ1 regulated AR activity using the human adrenal carcinoma cell line, SW13, which is deficient in both BRG1 and Brm expression and considered to lack functional SWI/SNF complexes [30].